covid
Buscar en
Endocrinología y Nutrición
Toda la web
Inicio Endocrinología y Nutrición Transformación anaplásica tardía de dos bocios multinodulares
Información de la revista
Vol. 53. Núm. 8.
Páginas 515-518 (octubre 2006)
Compartir
Compartir
Descargar PDF
Más opciones de artículo
Vol. 53. Núm. 8.
Páginas 515-518 (octubre 2006)
Notas clínicas
Acceso a texto completo
Transformación anaplásica tardía de dos bocios multinodulares
Late anaplastic transformation of two multinodular goiters
Visitas
4478
Elena García Fernández
Autor para correspondencia
elenagarciafer@terra.es

Correspondencia: Dra. E. García Fernández. Servicio de Endocrinología y Nutrición. Hospital Universitario 12 de Octubre. Av. de Córdoba, s/n. 28041 Madrid. España.
, Helena Requejo Salinas, Sharona Azriel Mira, Federico Hawkins Carranza
Servicio de Endocrinología y Nutrición. Hospital Universitario 12 de Octubre. Madrid. España
Este artículo ha recibido
Información del artículo

El carcinoma anaplásico de tiroides es un tumor muy agresivo con una supervivencia media de 3 a 7 meses. El 50% se desarrolla a partir de bocios multinodulares de larga evolución y el 20-30% coexiste con carcinomas diferenciados. Presentamos los casos de 2 pacientes ancianas con bocio multinodular en seguimiento durante años que sufrieron, de forma brusca, una transformación anaplásica. Ante esta posibilidad, y dado el pronóstico infausto de este tipo de carcinoma, se aconseja realizar un seguimiento de por vida en estos pacientes.

Palabras clave:
Bocio multinodular
Carcinoma anaplásico
Masa cervical

Anaplastic thyroid carcinoma is a highly aggressive tumor with a mean survival of 3-7 months. Up to one half of patients have long-standing multinodular goiter and 20-30% have a coexisting differentiated carcinoma. We present two elderly patients under follow-up for multinodular goiters that suddenly showed anaplastic transformation many years after the initial diagnosis. Given the possibility of malignant transformation and the fatal prognosis of this carcinoma, life-long surveillance of these patients is advisable.

Key words:
Multinodular goiter
Anaplastic thyroid carcinoma
Cervical mass
El Texto completo está disponible en PDF
Bibliografía
[1.]
E.L. Mazzaferri.
Undifferentiated thyroid carcinoma and unusual thyroid malignancies.
Endocrine Tumors, pp. 378
[2.]
L.A. Akslen, T. Haldorsen, S. Thoresen, E. Glattre.
Incidence of thyroid cancer in Norway 1970-1985.
Acta Pathol Microbiol Immunol Scand, 98 (1990), pp. 549-558
[3.]
J.L. Hunt, M. Tometsko, P. Swalsky, S.D. Finkelstein, E. Leon.
Molecular evidence of anaplastic transformation in coexisting well-differenciated and anaplastic carcinomas of the thyroid.
Am J Surg Pathol, 27 (2003), pp. 1559-1564
[4.]
C.J.C. Nel, J.A. Van Heerden, J.R. Goellner, H. Gharib, W.M. McConahey, W.F. Taylor, et al.
Anaplastic carcinoma of the thyroid: a clinical pathology study of 82 cases.
Mayo Clin Proc, 60 (1985), pp. 51-58
[5.]
V. Zivaljevic, H. Vlajinac, R. Jankovic, J. Marinkovic, A. Diklic, I. Paunovic.
Case-control study of anaplastic thyroid cancer.
Tumori, 90 (2004), pp. 9-12
[6.]
H. Asakawa, T. Kobayashi.
Multistep carcinogenesis in anaplastic thyroid carcinoma:a case report.
Pathology, 34 (2002), pp. 94-97
[7.]
G. García-Rostán, G. Tallín, A. Herrero, T.G.D. Aquila, M.L. Carcangiu, D.L. Rimm.
Frequent mutation and nuclear localitation of B-catetin in anaplastic thyroid carcinoma.
Cancer Res, 59 (1999), pp. 1811-1815
[8.]
S. Pilloti, P. Collini, F. Rilke, G. Cattoretti, R. Del Bo, M.A. Pierotti.
Bcl-2 protein expression in carcinomas originating from the follicular epithelium of the thyroid gland.
J Pathol, 172 (1994), pp. 337-342
[9.]
S. Wang, R.V. Lloyd, M.J. Hutzler, M.S. Safran, M.A. Patwardhan, A. Khan.
The role of cell cycle regulatory protein, cyclin D1, in the progression of the thyroid cancer.
Mod Pathol, 13 (2000), pp. 882-887
[10.]
J.D. Bergstrom, A. Hermansson, T. Díaz de Stahl, N.E. Heldin.
Non-autocrine, constitutive activation of met in human anaplastic thyroid carcinoma cells in culture.
Br J Cancer, 80 (1999), pp. 650-656
[11.]
C. Hoang-Vu, H. Dralle, G. Scheumann, C. Maenhaut, R. Horn.
Gene expression of differentiation and dedifferentiation markers in normal and malignant human thyroid tissues.
Exp Clin Endocrinol, 100 (1992), pp. 51-56
[12.]
M. Zou, Y. Shi, S. Al-Sedairy, N.R. Farid.
High levels of Nm23 gene expresión in advenced stage of thyroid carcinomas.
Br J Cancer, 68 (1993), pp. 385-388
[13.]
V.B. Wreesmann, R.A. Ghossein, S.G. Patel, C.P. Harris, E.A. Schnaser, A.R. Shaha, et al.
Genome-wide appraisal of thyroid cancer progression.
Am J Pathol, 161 (2002), pp. 1549-1556
[14.]
G.Y. Lip, A.J. Jaap, D.C. McCruden.
A presentation of anaplastic carcinoma of the thyroid with syntomatic intra-abdominal metastases.
Br J Clin Pract, 46 (1992), pp. 143-144
[15.]
M. Glikson, R.D. Feigin, E. Libson, A. Rubinow.
Anapastic thyroid carcinoma in a retroesternal goiter presenting as fever of unkown origin.
Am J Med, 88 (1990), pp. 81-82
[16.]
T. Hanslik, P. Gepner, B. Franc, A.C. Baglin, O. Bletry, A. Baglin.
Anaplastic cancer of the thyroid gland disclosed by prolongued fever or hyperleukocytosis. Two cases [carta].
Ann Med Inter (Paris), 147 (1996), pp. 122-124
[17.]
T.C. Chang, K.Y. Liaw, S.H. Kuo, C.C. Chang, F.W. Chen.
Anaplastic thyroid carcinoma: review of 24 cases, with emphasis on cytodiagnosis and leucocytosis.
Taiwan I Hsueh Hui Tsa Chih, 88 (1989), pp. 551-556
[18.]
R.H. Nishiyama, E.L. Dunn, N.W. Thompson.
Anaplastic spindlecell and giant-cell tumors of the thyroid gland.
Cancer, 30 (1972), pp. 113-127
[19.]
R.K. Tan, R.K. Finley, D. Driscoll, V. Bakamjian, W.L. Hicks Jr, D.P. Shedd.
Anaplastic carcinoma of the thyroid: a 24-year experience.
Head Neck, 17 (1995), pp. 41-47
[20.]
M.L. Carcangiu, T. Steeper, G. Zampi, J. Rosai.
Anaplastic thyroid carcinoma: a study of 70 cases.
Am J Clin Pathol, 83 (1985), pp. 135-158
[21.]
Y.S. Venkatesh, N.G. Ordóñez, P.N. Schultz, R.C. Hickey, H. Goepfert, N.A. Samaan.
Anaplastic carcinoma of the thyroid: a clinicopathologic study of 121 cases.
Cancer, 66 (1990), pp. 321-330
[22.]
T. Hadar, C. Mor, G. Har-El, J. Sidi.
Anaplastic thyroid carci-noma metastasic to the tonsil.
J Laryngol Otol, 101 (1987), pp. 953-956
[23.]
D.L. Phillips, K.G. Benner, E.B. Keeffe, S.T. Traweek.
Isolated metastasis to small bowel from anaplastic thyroid carcinoma. With a review of extra-abdominal malignancies that spread to the bowel.
J Clin Gastroenterol, 9 (1978), pp. 563-567
[24.]
H. Murabe, T. Akamizu, A. Kubota, S. Kusaba.
Anaplastic thyroid carcinoma with prominent cardiac metastasis, accompanied by a marked leukocytosis with a neutrophilia nad high GM-CSF level in serum.
Int Med, 31 (1992), pp. 1107-1111
[25.]
T. Hadar, C. Moh, J. Shvero, R. Levy, K. Segal.
Anaplastic carcinoma of the thyroid.
Eur J Surg Oncol, 19 (1993), pp. 511-516
[26.]
T. Murakami, S. Noguchi, N. Murakami, J. Tayiri, Y. Ohta.
Destructive thyrotoxicosis in a patient with anaplastic thyroid cancer.
Endocrinol Jpn, 36 (1989), pp. 905-907
[27.]
A. Oppenheim, M. Miller, G.H. Anderson Jr, B. Davis, T. Slagle.
Anaplastic thyroid cancer presenting with hypertyroidism.
Am J Med, 75 (1983), pp. 702-704
[28.]
B. McIver, I.D. Hay, D.F. Giuffrida, C.E. Dvorak, C.S. Grant, G.B. Thompson, et al.
Anaplastic thyroid carcinoma: a 50 year experience at a single institution.
Surgery, 130 (2001), pp. 1028-1034
[29.]
J.R. Spires, M.R. Schwartz, R.H. Miller.
Anaplastic thyroid carcinoma: Association with differentiated thyroid cancer.
Rch Otolaryngol Heat Neck Surg, 114 (1988), pp. 40-44
[30.]
S.I. Sherman, J. Brierley, M. Sperling, K.B. Ain, S.T. Bigos, D.S. Cooper, et al.
Prospective multicenter study of thyroid carcinoma treatment: initial analysis of staging and outcome. National thyroid cancer treatment. Cooperative Study Registry Group.
Cancer, 83 (1998), pp. 1012-1021
[31.]
I. Sugitani, N. Kasai, Y. Fujimoto, A. Yanagisawa.
Prognostic factors and therapeutic strategy for anaplastic carcinoma of the thyroid.
World J Surg, 25 (2001), pp. 617-622
[32.]
S.I. Sherman.
Thyroid carcinoma.
Lancet, 361 (2003), pp. 501-511
Copyright © 2006. Sociedad Española de Endocrinología y Nutrición
Opciones de artículo
es en pt

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos